WO2004021803A1 - 精製ローヤルゼリー - Google Patents
精製ローヤルゼリー Download PDFInfo
- Publication number
- WO2004021803A1 WO2004021803A1 PCT/JP2003/011311 JP0311311W WO2004021803A1 WO 2004021803 A1 WO2004021803 A1 WO 2004021803A1 JP 0311311 W JP0311311 W JP 0311311W WO 2004021803 A1 WO2004021803 A1 WO 2004021803A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- royal jelly
- water
- purified
- mass
- protein
- Prior art date
Links
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 180
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 103
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 103
- 239000000203 mixture Substances 0.000 claims abstract description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 61
- 239000002244 precipitate Substances 0.000 claims abstract description 48
- 239000000126 substance Substances 0.000 claims abstract description 42
- 239000006228 supernatant Substances 0.000 claims abstract description 38
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 15
- 230000000144 pharmacologic effect Effects 0.000 claims abstract description 13
- 238000002523 gelfiltration Methods 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- 150000001720 carbohydrates Chemical class 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 13
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 235000006708 antioxidants Nutrition 0.000 claims description 9
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 7
- 235000021588 free fatty acids Nutrition 0.000 claims description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- -1 cyclic tetrasaccharide Chemical class 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 229930003935 flavonoid Natural products 0.000 claims description 3
- 150000002215 flavonoids Chemical group 0.000 claims description 3
- 235000017173 flavonoids Nutrition 0.000 claims description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 40
- 235000018102 proteins Nutrition 0.000 description 95
- 239000012223 aqueous fraction Substances 0.000 description 23
- 239000000047 product Substances 0.000 description 20
- 239000000306 component Substances 0.000 description 19
- 239000000499 gel Substances 0.000 description 17
- 239000012528 membrane Substances 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 238000001155 isoelectric focusing Methods 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000002009 allergenic effect Effects 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 12
- 229910021641 deionized water Inorganic materials 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 235000015110 jellies Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000005194 fractionation Methods 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 238000005119 centrifugation Methods 0.000 description 10
- 239000008274 jelly Substances 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 241000257303 Hymenoptera Species 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- QHBZHVUGQROELI-UHFFFAOYSA-N 10-hydroxydec-2-enoic acid Chemical compound OCCCCCCCC=CC(O)=O QHBZHVUGQROELI-UHFFFAOYSA-N 0.000 description 8
- 235000013402 health food Nutrition 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 230000000172 allergic effect Effects 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- KUPHXIFBKAORGY-UHFFFAOYSA-N 2-amino-3-iodo-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(N)=C1I KUPHXIFBKAORGY-UHFFFAOYSA-N 0.000 description 6
- 241000124008 Mammalia Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 102100040247 Tumor necrosis factor Human genes 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000001223 reverse osmosis Methods 0.000 description 6
- 235000000346 sugar Nutrition 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000001641 gel filtration chromatography Methods 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 235000015243 ice cream Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 229940041672 oral gel Drugs 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- 229940025878 hesperidin Drugs 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000013555 soy sauce Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- QHBZHVUGQROELI-SOFGYWHQSA-N (E)-10-hydroxydec-2-enoic acid Chemical compound OCCCCCCC\C=C\C(O)=O QHBZHVUGQROELI-SOFGYWHQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- NWPRCRWQMGIBOT-UHFFFAOYSA-N 7-(2-hydroxyethyl)-1,3-dimethylpurine-2,6-dione Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CCO)C=N2 NWPRCRWQMGIBOT-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 102100027765 Atlastin-2 Human genes 0.000 description 1
- 101710192135 Atlastin-2 Proteins 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- RNTJDJDUXWVMJY-UHFFFAOYSA-N CC(C)(OC(=O)C(=O)c1ccc(O)cc1)C1Cc2cc3ccc(=O)oc3cc2O1 Chemical compound CC(C)(OC(=O)C(=O)c1ccc(O)cc1)C1Cc2cc3ccc(=O)oc3cc2O1 RNTJDJDUXWVMJY-UHFFFAOYSA-N 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000504 effect on taste Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 210000003499 exocrine gland Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000004463 hay Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 150000002641 lithium Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 238000007591 painting process Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 150000003243 quercetin Chemical class 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-M thioglycolate(1-) Chemical compound [O-]C(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-M 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
- A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
- A23G9/38—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to purified royal jelly.
- this method is used for a purification port—jar jelly and a method for producing the same, which are reduced by less than 50% by mass relative to the total protein mass.
- Royal jelly is a milky secretion from the exocrine glands of worker bees that accumulates in the nest of bees' nests (bunches of queen bees) and is fed to larvae to become queen bees. It is a leaky substance. Its chemical composition varies slightly depending on the place of production, season, etc., but the water content is 65-75% (wZw) and the protein is 15-20% (w / w) Carbohydrate ⁇ 0- ⁇ 5% (ww), fat 1.7-6% (w / w), ash 0.7-2% (wZw), 10-hydroxy-1-2-decenoic acid and other organic substances It also contains acids, various vitamins, and various minerals.
- proteins contained in royal jelly are classified into water-soluble proteins and water-insoluble proteins.
- the former accounts for about 75% of the total protein and the latter for about 25%.
- Royal jelly has been widely used as a health food for humans since ancient times, and recently has a useful pharmacological action on the human body, for example, There have been many reports that it has a bactericidal action, an immunopotentiating action, an antitumor action, an anti-inflammatory action, a life extension action, and the like.
- Japanese Patent Application Laid-Open No. 2002-112127 discloses a method in which royal jelly is treated with a glycolytic enzyme and a protease to reduce a low allergen. A method for conversion is disclosed.
- this royal jelly which is obtained by precipitating a water-soluble protein, which becomes an allergenic substance, by isoelectric focusing, decomposing it with a glycolytic enzyme, and decomposing it with a proteolytic enzyme, makes the added enzyme itself. There is a problem that it may become a new allergenic substance and is not preferred as royal jelly that is taken for health purposes. Disclosure of the invention
- the present invention has been made in view of such a situation, and there is a concern that allergenicity is reduced and allergic symptoms are caused, while royal jelly's original useful pharmacological action is maintained. It is an object of the present invention to provide a use of a composition comprising a small amount of purified mouth jelly and a method for producing the same, and a purified royal jelly in foods and drinks, feeds, feeds, pet foods or cosmetics.
- untreated royal jelly may be simply referred to as “royal jelly” or “raw royal jelly”.
- RJ This may be abbreviated as a raw material). Water is added to the mixture, and the mixture is separated into a supernatant and a precipitate by centrifugation, and raw royal jelly is used as a control for each of the components.
- water fractionation step a step of adding water to raw royal jelly and centrifuging to separate into supernatant and precipitate
- this step is abbreviated as “water fractionation step” in this specification, and this operation is referred to as “water fractionation”.
- a step of removing high molecular substances including water-soluble proteins and collecting low molecular substances by ultrafiltration or gel filtration of the supernatant hereinafter referred to as “polymer removal” in the present specification).
- Step the step of combining the low-molecular substance obtained by the ultrafiltration or gel filtration with the precipitate (hereinafter, abbreviated as “mixing step” in the present specification).
- the water-soluble protein is reduced to less than 50% by mass relative to the total protein mass (hereinafter, unless otherwise specified, the mass% is simply abbreviated to%). Reduces allergenicity and raw royal jelly As a unique finding, it was possible to prepare purified royal jelly while retaining the useful pharmacological action inherently possessed.
- the present invention provides a purified royal jelly having a water-soluble protein content reduced to less than 50% of the total protein content, a method for producing the same, and a composition comprising the purified royal jelly. And the use of the composition in foods, drinks, feeds, feeds, pet foods or cosmetics.
- the purpose is to solve the above-mentioned problems by providing a way.
- the present invention relates to a purified royal jelly in which the amount of water-soluble protein is reduced to less than 50% of the total amount of protein.
- Raw royal jelly used as a raw material of the purified royal jelly of the present invention is not particularly limited in the type of bee to be secreted, the place of its production, and the supply form (raw or frozen).
- the seeds of bees that secrete are: A. bees (A pisme II ifera), A. bees (A. piscerana), A. bees (A. pisdorsata), and A. pisf I orea).
- the localities include Japan, South America, North America, Australia, China, Europe and others.
- any of these royal jellies can be advantageously used as a raw material for the purified royal jelly of the present invention, it is more preferable to use fresh-mouth jars that are as fresh as possible or stored at low temperatures. Desirable.
- the purified royal jelly of the present invention has a water-soluble protein content of less than 50% based on the total protein mass within a range that does not substantially lose the useful pharmacological action inherent to royal jelly. Preferably less than 40%, more preferably less than 20%, even more preferably less than 10%, and thereby allergenicity is reduced. Is good.
- the protein quantification in the present invention is carried out by the method of Lowry, which is a commonly used protein quantification method in the art (0. H. Lowry et al., Jianraire's Biologiole Chemistry). According to the tree (Journal Biological Chemistry), Vol. 193, pp. 265, 1951, ⁇ ⁇ Use serum albumin as the standard protein.
- the allergenicity contained in oral jelly can be confirmed by the measurement method described in the experimental examples described later.
- the purified royal jelly of the present invention well retains 10-hydroxy-12-decenoic acid, which contributes to the original useful pharmacological action of royal jelly, but causes allergenicity. It reduces protein, which is a high molecular substance, and its physicochemical index includes the mass ratio of total protein to 10-hydroxy-2--2-decenoic acid in terms of free fatty acid,
- the ratio of the purified royal jelly of the present invention is less than 6. This mass ratio is generally in the range of 7 to 15 in the case of raw royal jelly, and can be clearly distinguished from that of the purified royal jelly of the present invention.
- 10-hydroxyl-2-decenoic acid can be quantified by a measurement method described in an experimental example described later.
- the purified royal jelly of the present invention is obtained by subjecting a protein contained in the purified royal jelly to gel isoelectric focusing in the presence of 8 M urea in a pH range of 3 to 10 to give a protein having an isoelectric point of less than 5. It can also be specified by measuring the ratio of proteins having an isoelectric point of 5 or more according to the experimental examples described later.
- the ratio of the protein having an isoelectric point of 5 or more to the protein having an isoelectric point of less than 5 is 1 or more, and is clearly distinguished from the raw royal jelly which shows less than 1. Can be.
- the method for purifying royal jelly may be any method capable of removing allergenicity without substantially losing the useful pharmacological action inherent to royal jelly. Less than 50%, more preferably less than 40%, relative to total protein Preferably, it can be reduced to less than 20%, more preferably to less than 10%.
- Specific purification methods include, for example, water dilution, centrifugation, membrane filtration, filtration, concentration, fractionated precipitation, salting out, dialysis, ion exchange chromatography, gel filtration chromatography, and gel filtration chromatography.
- the method for producing purified royal jelly of the present invention comprises a combination of a water fractionation step, a high molecular weight removal step, and a mixing step.
- a water fractionation step water dilution and centrifugation are used in the water fractionation step.
- methods such as membrane separation and gel filtration chromatography are useful, but membrane separation is more preferred because it can be performed more easily.
- the water-soluble protein can be transferred to the supernatant when water is added to Ikuchi-j jar jelly in the water fractionation step and centrifuged to separate from the water-insoluble precipitate.
- the total protein content as referred to in the present invention means the sum of the protein content of the supernatant (the mass of the water-soluble protein) and the protein mass of the precipitate.
- This step is a step of separating the royal jelly into a supernatant and a precipitate by water fractionation.
- the water added to the royal jelly is not particularly limited, and if necessary, for example, ultrapure water, ion-exchanged water, distilled water, magnetized water, mineral water, tap water, deep ocean water Any of these can be advantageously used.
- a buffer may be used to maintain the pH of the aqueous solution in which royal jelly is suspended or dissolved within a certain range.
- the pH of the aqueous solution in which royal jelly is suspended or dissolved is usually in the range of pH 3.5 to 4.5, there is no particular need to adjust the pH. However, when the pH is less than 3.5, the acidity becomes strong, which is inconvenient for processing as food. If the pH is higher than 4.5, the protein, which is originally water-soluble, may undergo isoelectric precipitation to form a precipitate, which is not suitable for a water fraction.
- the amount of water added to the royal jelly varies depending on the number of repetitions of the water fraction, usually 1 to 100 times the mass of the raw royal jelly is used, and preferably 1 to 100 times. Double doses are used. If the amount of water to be mixed is too small, the solubility of the water-soluble protein will be insufficient, and the separation of the supernatant and the precipitate will also be insufficient. Further, if too much water is added, it takes a long time for production, leading to deterioration of effective components, and is not preferable in terms of work efficiency.
- the water fraction may be centrifuged once using a relatively large amount of water, or may be divided into several times using a relatively small amount of water.
- the water fraction when adding about 4 times the amount of raw royal jelly water, the water fraction It is desirable to repeat the steps at least once, and preferably at least twice.
- the centrifugation is not limited as long as it can sufficiently separate the supernatant and the precipitate, and any of a batch system and a continuous system can be advantageously used.
- the conditions of centrifugation depend on the centrifugal force used and the time of centrifugation, but are usually 10 minutes or more at a centrifugal force of 3, OOOX g, and preferably at 5,000 X g. It is preferable to carry out the treatment for at least 0 minutes, more preferably at 10 0,000 Xg for at least 10 minutes.
- the allergenic supernatant obtained by the water fractionation step contains a water-soluble protein which is a high molecular substance, while useful 10-hydrogen which is originally contained in oral jelly is used.
- Low molecular weight substances such as organic acids such as xyl-2-decenoic acid, amino acids, carbohydrates and vitamins Included at the same time.
- the substances present in the supernatant are separated into high molecular substances and low molecular substances by ultrafiltration or gel filtration, high molecular substances including water-soluble proteins are removed, and useful low molecular substances are removed. This is the sampling process.
- the water-soluble protein, which is a high molecular substance can be effectively removed by membrane separation using an ultrafiltration membrane of a pore size that cannot pass through.
- an ultrafiltration membrane for example, an ultrafiltration membrane selected from a molecular weight cut-off of 1,000 to 10,000,000 daltons is preferable. If the molecular weight cut-off is less than 1,000 daltons, there is a concern that even low molecular weight substances may be removed. There is concern that some of the quality will be mixed. It is also possible to separate the low molecular weight substance and the high molecular weight substance by gel filtration chromatography, etc., and such a method may be used in the polymer removal step of the present invention, but the work efficiency and Considering industrial applications, it is preferable to use an ultrafiltration membrane.
- This step is a step in which the useful low-molecular substance collected in the polymer removal step is mixed with the precipitate to obtain the purified royal jelly of the present invention.
- the low molecular weight substance obtained by ultrafiltration or gel filtration may be directly mixed with the precipitate.
- the low-molecular substance obtained by ultrafiltration or gel filtration is often diluted much more than the original concentration in the raw material, and in such a case, the low-molecular substance is used as necessary.
- the membrane concentration is preferred because there is less concern such as thermal denaturation of the active ingredient contained in the royal jelly.
- concentration using a reverse osmosis membrane any membrane capable of recovering the water-soluble low-molecular substance contained in royal jelly into the concentrated solution side may be used.
- the salt cut rate is preferably 75% or more. More than 90%, more preferably more than 95% of reverse osmosis membrane is used.
- the ratio of the mass of the water-soluble protein to the total mass of the protein is reduced to less than 50%, and accordingly, the allergenic substance contained in the royal jelly Health foods intended to maintain and promote health, since the amount of preservatives has been reduced and the useful pharmacology such as anti-inflammatory activity and lifespan extension inherent to royal jelly has not been substantially lost. It can be used advantageously.
- the purified royal jelly of the present invention is useful on its own, but can also be advantageously used in the form of a composition mixed with other components.
- the present invention also provides such a composition.
- the composition according to the present invention usually contains one or more components that are orally or transdermally applicable to mammals including humans or are externally acceptable to the skin, together with the purified royal jelly.
- it can be advantageously used in the food field, the beverage field, the feed / feedstuff / pet food field, the cosmetics field, and the like.
- a component used in the present invention that is acceptable for oral or transdermal application to mammals including humans or for external application to the skin it is commonly used in the respective fields of application of the composition of the present invention.
- compositions of the present invention containing the above components, and the composition is provided in a desired form such as a powder, a granule, a tablet, a paste, an emulsion or a solution.
- the composition and the content of each of the above-mentioned components are determined according to the purpose, that is, the type of the target mammal or the like. They may be mixed according to an appropriate composition selected according to the method of ingestion and the like, appropriately subjected to treatments such as dilution, concentration, drying, filtration, centrifugation and the like, and formed into a desired shape as required.
- the order of blending each component and the timing of various treatments are not particularly limited as long as the quality of the purified royal jelly is not deteriorated.For example, as soon as possible or at a low temperature after preparation.
- the purified royal jelly thus obtained is mixed, and then, if necessary, various treatments may be appropriately performed.
- all of the above steps are preferably carried out under normal temperature, preferably 30 ° C or lower.
- the composition containing the purified royal jelly of the present invention can be made into a solid form by mixing the purified royal jelly with anhydrous carbohydrate, and then drying it. Granules and tablets can also be used.
- the anhydrous saccharide include anhydrous ⁇ , ⁇ -trehalose, anhydrous maltose, and anhydrous cyclic tetrasaccharide.
- Anhydrous, -trehalose was obtained from commercially available trehalose-2 hydrous crystal (Hayawara Shoji Co., Ltd., registered trademark "Treha”) by the method disclosed in Patent No. 3168550. Easy to prepare, for the above purpose Can be used.
- anhydrous maltose commercially available anhydrous crystalline maltose (Hayashibara Shoji Co., Ltd., registered trademark “Finethose”) can be advantageously used.
- anhydrous cyclic tetrasaccharide it is possible to advantageously carry out the use of the anhydrous cyclic tetrasaccharide disclosed in International Publication W002Z057011.
- composition comprising the purified royal jelly and the anhydrous saccharide according to the present invention may be prepared, for example, by mixing the purified royal jelly with the anhydrous saccharide and, if necessary, further mixing other components. Can be obtained by subjecting the same to a dehydration drying force and, if necessary, to a normal drying step such as reduced-pressure drying, vacuum drying, and heating. More specifically, crystalline or non-crystalline anhydrous saccharide is usually added to purified royal jelly in an amount of at least 4 times, preferably 8 times, the mass of purified royal jelly. After mixing, the mixture is mixed at room temperature or lower, desirably at 30 ° C or lower, usually for 4 hours or longer, desirably 8 hours.
- the purified royal jelly in the solid form thus prepared may be further subjected to a drying step, if necessary, to obtain powders, granules, tablets using a pulverizer, a granulator, a tableting machine, or the like.
- the powder or the granules can be advantageously used by filling the capsules in the desired form or, if necessary, for example.
- glycosyltransferred vitamin C also known as L-ascorbic acid 2-glucoside
- L-ascorbic acid 2-glucoside a commercially available glycosyltransferred vitamin C
- L-ascorbic acid 2-glucoside a commercially available glycosyltransferred vitamin C
- glycosyltransferred vitamin C is a chemically stable substance. And it is degraded for the first time in the body to release ascorbic acid.
- an antioxidant is further added to the composition of the present invention, whereby the active ingredient contained in the purified royal jelly can be further stabilized. Therefore, according to the application target of the composition, the applicable area, and the like, the composition can be advantageously implemented, for example, when the composition is transported by a ship or the like without temperature control or when used in a high-temperature area.
- the antioxidant used in the present invention is not limited to a specific type, when the composition is used as food for mammals including humans, the antioxidant may be any of those commonly used in the food field. It is desirable to select an appropriate one. Specific examples of antioxidants commonly used in the food field include flavonoids, polyphenols, vitamin E, vitamin C, and the like.
- glycosynthetic rutin which is composed of rutin, hesperidin, naringin, quercetin, and saccharides such as glucose or a polymer thereof, respectively, Glycosylated hesperidin, glycosylated naringin, glycosylated quercetin, and the like.
- Polyphenols include, more particularly, techotechnics and gallic acid.
- plant extracts such as enchyma extract, rosemary extract and eucalyptus extract, can also be advantageously used as antioxidants in the present invention.
- the content of these antioxidants in the composition is not particularly limited, when the composition is used as food, the content of the antioxidant in the composition usually used in the food field is considered in consideration of the effect on taste. It is desirable to use the force according to or below.
- Desirable food forms of the composition of the present invention include, for example, Ice cream, ice cream, ice cream and other confectionery, ice honey and other syrups, butter cream, custard cream, flower paste, and pinna Spreads and pastes such as butter paste, fruit paste, chocolate, jelly, candy, gummy jelly, caramel, chuin Western confectionery such as gum, pudding, shou cream and sponge cake, processed fruits or processed vegetables such as jams,ment, syrup pickles, confectionery, etc.
- Desirable beverage forms include, for example, liquors such as synthetic liquor, brewed liquor, fruit liquor, and Western liquor, juices, mineral drinks, carbonated drinks, lactic acid drinks, lactic acid drinks, sports drinks, and drinks. Drinks such as ink, tea, black tea, oolong tea, coffee and cocoa.
- the purified royal jelly of the present invention may be used as it is or in the form of a composition containing other components, for example, for livestock, poultry, pets, and other domestic animals such as bees, silkworms, silkworms, insects, and fish. It can also be used advantageously as feed, feed, pet food, etc.
- compositions having such a form include those commonly used in each field, for example, foods, starches, sucrose, sugars, oils, fats, seeds, beans, Seafood, meat, eggs, milk, plant protein extracts, fruits, mushrooms, algae, vitamins, minerals, amino acids, and others, yeast, pasture, bagasse, corn cob, rice
- feed, feed, and pet food components such as straw, hay, oil cake, bran, soybean casks, and various fermentation basins are included.
- a solid such as powder, granules, tablets, pastes and gums, or a liquid such as an emulsion or a drink.
- Desirable cosmetic forms of the composition of the present invention include, for example, in the form of lotions, emulsions or creams, basic cosmetics, washing cosmetics, bathing cosmetics, hair cosmetics, tanning and sunscreen Cosmetics, make-up cosmetics, hair growth agents, hair restorers, etc.
- the purified royal jelly of the present invention may be added at an appropriate time during the process of producing a target product according to a conventional method. There is no particular limitation on the timing of addition, but if the target product is manufactured through a heating step, add it after cooling to room temperature, preferably 30 ° C or less, after the heating step. This can prevent the useful pharmacological action from attenuating during the manufacturing process.
- the composition of the present invention as described above contains the purified royal jelly of the present invention in an amount of usually from 0.01 to 20%, preferably from 0.01 to 1%, per product mass. Contains 10%.
- composition according to the present invention as described above has reduced allergenicity and stabilizes various useful pharmacological actions, so that useful pharmacological actions are effectively exhibited in the living body used.
- the body's resistance can be increased, illness can be improved sooner, and a healthy state can be maintained. Therefore, the composition of the present invention is extremely useful as foods, beverages, feeds, feeds, pet foods, cosmetics and the like for maintaining and improving health.
- test animals per test group 9-week-old, Nippon Chills River Co., Ltd.
- a 5 m g / mouse were immunized by intraperitoneal dosing.
- blood was collected from the tail vein of each mouse, and serum was collected using a microclonal mouse and subjected to a PCA method using a rat.
- mice serum diluted (100-fold or 200-fold) with physiological saline was injected intradermally in 0.1 mI increments onto the hair-removed back of a normal SD rat.
- the same preparation as that administered to the mice was administered intravenously with 7.5 mg of raw royal jelly together with 1 ml of 0.5% Evans blue dye solution, and serum was administered The size of the blue spot observed at the site was measured. Those showing spots with an average diameter of 5 mm or more were judged to be positive, those that were positive in 5 test groups and 5 brass (++++) and those that were negative in all 5
- the allergenicity was evaluated as negative (I).
- Table 1 The test results for the supernatant and precipitate of Brazilian royal jelly and the control are shown in Table 1, and Table 2 for Chinese royal jelly. table 1
- the ratio of the water-soluble protein to the total amount of protein in the precipitate can be reduced to less than about 40% and the allergenicity can be significantly reduced by performing the water fraction once. found.
- the supernatant of the first and second water fractions is combined into the supernatant liquid of the water fraction, and a pencil-type ultrafiltration membrane (available from Asahi Kasei Co., Ltd., trade name: “AIP 013”, molecular weight cut off)
- the solution was subjected to ultrafiltration using 600,000 daltons). It was water-flushed with a small amount of water to separate it into an ultrafiltrate and an ultrafiltrate concentrate. By ultrafiltration The obtained filtrate was finally combined with the precipitate to obtain purified royal jelly. It is a component specific to royal jelly as an index of protein, carbohydrate, and active ingredient in the samples at each operation stage, and is said to be involved in sugar metabolism and aging prevention.
- the water-soluble protein which accounts for the majority of the protein in the amount of 660 mg, was transferred to the supernatant by the water fractionation treatment, of which 830 mg, that is, nearly 90%, was converted to the ultrafiltration concentrate. It was found that it could be removed.
- useful low-molecular substances such as carbohydrates in raw royal jelly and 10-hydroxydi-2-decenoic acid, which are transferred to the supernatant at the same time as the water-soluble protein with relatively allergenic properties, are transferred to the supernatant.
- Substances were collected by filtration of the supernatant by further ultrafiltration, collecting the filtrate, and combining with the sediment to recover the sediment at a recovery rate of about 90% or more and 80% or more, respectively.
- the proteins contained in both the purified royal jelly and the raw royal jelly were separated into two large groups with an isoelectric point of 5 by gel isoelectric focusing.
- the gel after staining and decolorization is applied to a gel scanner (trade name “DUAL — WAVELENGTHCHROMATOSCA NNERCS-930”, manufactured by Shimadzu Corporation). Proteins with an isoelectric point of less than 5 and proteins with an isoelectric point of 5 or more was compared by measuring the area ratio of the absorbance peak at 600 nm.
- Table 7 shows the average results measured for four samples each of purified royal jelly and raw royal jelly. Table 7
- the protein having an isoelectric point of 5 or more in gel isoelectric focusing was about 42% of the total protein, while that of the purified royal jelly of the present invention accounted for about 57%. This suggests that the relatively allergenic water-soluble protein reduced by the water fractionation treatment contains a relatively large amount of protein having an isoelectric point of less than 5.
- the purified royal jelly of the present invention can be used for isoelectric focusing on proteins having an isoelectric point of less than 5 in gel isoelectric focusing in the range of pH 3 to 10 in the presence of 8 M urea as described herein. It can be said that the feature is that the quantity ratio of proteins showing points 5 or more is 1 or more.
- the first and second water fraction supernatants were combined into a water fraction supernatant, which was ultrafiltered with a molecular weight cut-off of 6,000 daltons (AIP 2 ).
- AIP 2 molecular weight cut-off of 6,000 daltons
- the mixture was filtered with a small amount of deionized water to separate it into ultrafiltrate and ultrafiltrate concentrate.
- About 160 L of this ultrafiltrate was subjected to reverse osmosis membrane. (Toyobo sales, registered trade pole “Holosep”) and concentrated to about 12 kg at a pressure of 50 kgf / cm 2. The obtained concentrated liquid and the precipitate of the centrifugation were combined.
- the purified royal jelly was prepared by stirring uniformly, and the mass ratio of the protein to 10-hydroxydi-2-decenoic acid in terms of free fatty acids in this refined oral jelly was 4.2.
- This purified royal jelly was subjected to gel isoelectric focusing, The ratio of the protein having an isoelectric point of 5 or more to the protein having an isoelectric point of less than 5 was about 1.2.
- the first and second water fractions were combined to give a water fraction supernatant, which was then subjected to gel filtration chromatography using Toyopearl HW-40F gel (Tosoh Ichi Co., Ltd.). It was served to the fee. It was eluted with deionized water and fractionated into a high molecular fraction and a low molecular fraction. The low-molecular fraction was concentrated to 8 parts by mass at 40 ° C using a reduced-pressure evaporator (manufactured by Shibata Kagaku Co., Ltd., RE-10E-100). The obtained concentrated solution and the precipitate obtained by the centrifugation were combined and uniformly stirred to prepare a purified royal jelly.
- the powder composition was formed into tablets of about 200 mg per tablet using a tableting machine.
- This product is a composition that can be easily used and has a significant effect.
- This product has a mild sweetness and moderate acidity, and is useful as a health food for daily use.
- Example B-2
- Example B-1 The following components were uniformly mixed with the following components, and then the same operation as in Example B-1 was performed to prepare a composition containing the purified royal jelly of the present invention in a powder form. After preparation, experiment according to Experiment 1. To confirm that the composition has reduced allergenicity.
- Glycosylated hesperidin (trade name "aG hesperidin PS", sold by Hayashibara Shoji Co., Ltd.)
- the purified royal jelly single-composition composition was formed into tablets of about 300 mg per tablet using a tableting machine.
- the product has reduced allergenicity, is a composition that can be conveniently used, and has a remarkable effect.
- This product has good taste with a mild sweetness and moderate acidity, and is useful as a health food to be used on a daily basis.
- Example B-3
- Example B-1 The following components were uniformly mixed with the following components, and then the operation was carried out according to Example B-1 to prepare a refined oral jar jelly composition of the present invention in a powder form. After preparation, an experiment was performed according to Experiment 1, and it was confirmed that the composition had reduced allergenicity.
- Raw cream (oil content: about 46% by mass) 18 parts by mass, 7 parts by mass of skim milk powder, 51 parts by mass of whole milk, 10 parts by mass of sugar, powder containing lactose (registered trademark " Emulsified Oligo ”) Dissolve a mixture of 4 parts by mass, 2 parts by mass of pullulan and 2 parts by mass of arabic gum, hold at 70 ° C for 30 minutes, sterilize, and emulsify and disperse with a homogenizer. Then, the mixture was quenched to 3 to 4 ° C, and 14 parts by mass of the purified royal jelly obtained by the method of Example A-2 was added thereto, further mixed and aged overnight. The ice cream was obtained by freezing it on a reservoir.
- Example A-1 10 parts by mass of white rice is cooked by adding water according to a conventional method, and then the obtained rice is cooled to 55 ° C. and 30 parts by mass of koji prepared by a conventional method. 0.1 parts by weight of common salt was mixed, kept at 50 to 55 ° C for 8 hours, mixed with the mixer, and cooled to about 25 ° C. Then, the method of Example A-1 was used. After adding and mixing 12 parts by mass of the purified royal jelly obtained in the above, the mixture was filled in a parcel to obtain amazake. This product is a high quality amazake with a good color tone and rich flavor, and is also useful as a beverage for maintaining and improving health.
- Anhydrous crystalline maltose 500 parts by mass
- Example A 100% by mass of purified royal jelly of ⁇ , powdered yolk 19 0 parts by mass, 200 parts by mass of skim milk powder, 2 parts by mass of glycosylated vitamin C (sold by Hayashibara Biochemical Laboratory Co., Ltd., registered trademark “AA2G”), 4.4 parts by mass of sodium chloride , 1.85 parts by mass of chlorinated lithium, 4 parts by mass of magnesium sulfate, 0.01 part by mass of thiamine, 0.1 part by mass of sodium ascorbate, and bismuth
- a mixture of 0.6 parts by mass of acetic acid E-acetate and 0.4 parts by mass of nicotinic acid amide was prepared. 25 parts by mass of this mixture were uniformly dispersed and dissolved in 150 parts by mass of purified water, and 150 g of each was sealed in a brown glass bottle.
- Example 1 One part by mass of purified royal jelly obtained by the method of Example A-1 and an appropriate amount of a fragrance were added and mixed uniformly. The resulting composition was dispensed into starch mold and allowed to stand overnight to prepare a gummy pot food.
- This product contains refined oral jelly that has reduced allergenicity, and is supplemented with nutrients, so it maintains the health of the pet, promotes growth, and prevents and treats diseases. It can be used advantageously as a feed hood for the purpose of promoting food.
- the product can be advantageously used as a composition for oral ingestion not only for dogs and cats but also for various animals such as pets and livestock.
- 1,3-Butylene glycol 50 parts by mass Sodium lactate solution 100 parts by mass Methyl para-xyloxybenzoate 0 1 part by mass Peach leaf extract 15 parts by mass Purified water 6 2 2 parts by mass
- Example A Purification mouth obtained by method 3
- This cream shows excellent moisturizing properties and also reduces the allergenicity of royal jelly, keeping the skin fresh without fear of causing allergic symptoms.
- purified royal jelly in which the ratio of the water-soluble protein content to the total protein content is reduced to less than 50%, has significantly reduced allergenicity to mammals including humans.
- it is based on a completely unique finding that it retains the useful pharmacology of royal jelly. Since the purified royal jelly has no fear of causing serious allergic symptoms, mammals including humans can be used simply and comfortably for maintaining and improving health.
- the purified royal jelly of the present invention having the above-mentioned features can be used in various compositions such as foods, beverages, feeds, feeds, pet foods, cosmetics, etc. by mixing with other components. It can be used advantageously as a product.
- the present invention is an invention having such remarkable effects, and is an invention having a great significance in contributing to the art.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Birds (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Feed For Specific Animals (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03794234A EP1547472A4 (en) | 2002-09-06 | 2003-09-04 | ROYAL REFINED JELLY |
US10/525,157 US20060159834A1 (en) | 2002-09-06 | 2003-09-04 | Refined royal jelly |
BR0306294-5A BR0306294A (pt) | 2002-09-06 | 2003-09-04 | Geléia real com menos alérgeno |
JP2004534159A JP4384981B2 (ja) | 2002-09-06 | 2003-09-04 | 精製ローヤルゼリー |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-262163 | 2002-09-06 | ||
JP2002262163 | 2002-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004021803A1 true WO2004021803A1 (ja) | 2004-03-18 |
Family
ID=31973151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/011311 WO2004021803A1 (ja) | 2002-09-06 | 2003-09-04 | 精製ローヤルゼリー |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060159834A1 (ja) |
EP (1) | EP1547472A4 (ja) |
JP (1) | JP4384981B2 (ja) |
KR (1) | KR20050057127A (ja) |
CN (1) | CN1688209A (ja) |
BR (1) | BR0306294A (ja) |
TW (1) | TW200418392A (ja) |
WO (1) | WO2004021803A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034938A1 (ja) * | 2003-10-07 | 2005-04-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | コラーゲン産生増強剤とその製造方法並びに用途 |
JP2006016387A (ja) * | 2004-06-04 | 2006-01-19 | Jrj Pharmaceutical Co Ltd | 新規なローヤルゼリー配合物 |
JP2008067632A (ja) * | 2006-09-13 | 2008-03-27 | Japan Royal Jelly Co Ltd | 動物用サプリメントおよびペット用サプリメント |
WO2008149838A1 (ja) * | 2007-06-04 | 2008-12-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 新規ローヤルゼリー分画物とその製造方法並びに用途 |
JP2009508477A (ja) * | 2005-09-19 | 2009-03-05 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 茶製造のための改良された方法 |
JP2010090112A (ja) * | 2008-09-11 | 2010-04-22 | Queen Bee Garden:Kk | 遺伝子発現抑制剤および遺伝子発現促進剤並びにそれらの検出方法 |
JP2012080828A (ja) * | 2010-10-12 | 2012-04-26 | Kato Bihoen Honpo:Kk | ローヤルゼリー |
KR20150136857A (ko) | 2014-05-28 | 2015-12-08 | 대한민국(농촌진흥청장) | 알레르기성이 감소된 수용성 로열젤리를 포함하는 피부 미백 및 노화방지용 화장료 조성물 |
US10004711B2 (en) | 2014-05-08 | 2018-06-26 | Dsm Ip Assets B.V. | Methods and compositions comprising 10-hydroxy-2-decenoic acid |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2892410B1 (fr) | 2005-10-21 | 2010-10-15 | Fabre Pierre Dermo Cosmetique | Nouveaux hydro-acides gras insatures et leur utilisation dermo cosmetologique |
FR2900026B1 (fr) * | 2006-04-21 | 2011-01-14 | Ballot Flurin Apiculteurs | Procede de traitement de matiere apicole pour la fabrication de cosmetiques ou produits a ingerer ou de produits de sante et dispositif utilise |
WO2010008005A1 (ja) * | 2008-07-16 | 2010-01-21 | 国立大学法人 琉球大学 | ストレスによって誘導される免疫機能変調改善剤 |
WO2011019654A1 (en) * | 2009-08-10 | 2011-02-17 | Stokely-Van Camp, Inc. | Method for suspending a flavonoid in a beverage |
NZ590143A (en) * | 2010-12-22 | 2013-12-20 | Manukamed Ltd | Anti-inflammatory proteins and methods of preparation and use thereof |
AU2013277858B2 (en) | 2012-06-22 | 2018-03-29 | Manukamed Holdings Limited Partnership | Anti-inflammatory proteins and peptides and methods of preparation and use thereof |
US20150173406A1 (en) * | 2012-07-09 | 2015-06-25 | North Carolina State University | Hypoallergenic food-grade protein matrices and uses thereof |
CN104127442A (zh) * | 2013-05-02 | 2014-11-05 | 彦臣生技药品股份有限公司 | 一种用于保护肝脏的组合物 |
WO2014196674A1 (ko) * | 2013-06-07 | 2014-12-11 | 주식회사 청진바이오텍 | 알러지성분이 분리된 분리정제봉독 제조방법 |
KR101681026B1 (ko) * | 2013-06-20 | 2016-12-02 | 대한민국 | 알레르기성이 감소된 수용성 로열젤리의 제조방법 및 이의 용도 |
GB201520144D0 (en) * | 2015-11-16 | 2015-12-30 | Univ Newcastle Upon Tyne And Yissum Res Dev Company Of The Hebrew University Of Jerusalem And Board | Bee nutrition |
CN106578411B (zh) * | 2016-12-23 | 2020-09-29 | 江西三同生物科技有限公司 | 一种饲用蜂王胎蛋白及其制备工艺 |
CN109007722A (zh) * | 2017-06-10 | 2018-12-18 | 南京老山药业股份有限公司 | 一种蜂王浆冻干粉的制造方法 |
CN109170736B (zh) * | 2018-10-24 | 2021-09-28 | 北京华润高科天然药物有限公司 | 一种蜂王浆的预处理方法及蜂王精口服液的制备方法 |
KR102324337B1 (ko) * | 2019-01-11 | 2021-11-11 | 김태욱 | 로열젤리 함유 토마토 음료 및 이의 제조방법 |
CN114437170A (zh) * | 2022-03-01 | 2022-05-06 | 中科梅奥(杭州)生物工程有限公司 | 一种从蜂王浆提取纯化的王浆主蛋白的方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04311357A (ja) * | 1991-04-05 | 1992-11-04 | Api Kk | ローヤルゼリーエキスの製造法 |
US5543513A (en) * | 1992-12-02 | 1996-08-06 | Kabushiki Kaisha Hayashibara | Trehalose desiccant product and dehydration therewith |
JPH11146759A (ja) * | 1997-11-18 | 1999-06-02 | Kirin Beverage Corp | 10−ヒドロキシ−2−デセン酸配合コーヒー含有飲料 |
JP2000060455A (ja) * | 1998-08-26 | 2000-02-29 | Api Co Ltd | ローヤルゼリーエキス及びローヤルゼリーエキス含有製品の製造方法 |
JP2001061418A (ja) * | 1999-08-30 | 2001-03-13 | Pola Chem Ind Inc | ローヤルゼリー中の有効成分の精製法 |
JP2002112715A (ja) * | 2000-10-03 | 2002-04-16 | Api Co Ltd | 低アレルゲン化ローヤルゼリー及びその製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2950201A (en) * | 1955-10-28 | 1960-08-23 | Golinelli Marino | Method of preserving royal jelly |
US5534513A (en) * | 1991-09-05 | 1996-07-09 | Taiho Pharmaceutical Company, Ltd. | Antitumor potentiator and antitumor composition |
JP3908872B2 (ja) * | 1999-02-16 | 2007-04-25 | ハウスウェルネスフーズ株式会社 | 澄明なローヤルゼリー乳化組成物およびその製造方法 |
JP2001029039A (ja) * | 1999-07-16 | 2001-02-06 | Pola Chem Ind Inc | ローヤルゼリー中の有効成分の精製法 |
AU2003261730A1 (en) * | 2002-08-29 | 2004-03-19 | Hayashibara, Ken | Antiallergic agent |
-
2003
- 2003-09-04 US US10/525,157 patent/US20060159834A1/en not_active Abandoned
- 2003-09-04 EP EP03794234A patent/EP1547472A4/en not_active Withdrawn
- 2003-09-04 WO PCT/JP2003/011311 patent/WO2004021803A1/ja active Application Filing
- 2003-09-04 CN CNA038237652A patent/CN1688209A/zh active Pending
- 2003-09-04 BR BR0306294-5A patent/BR0306294A/pt not_active IP Right Cessation
- 2003-09-04 KR KR1020057003666A patent/KR20050057127A/ko not_active Application Discontinuation
- 2003-09-04 JP JP2004534159A patent/JP4384981B2/ja not_active Expired - Fee Related
- 2003-09-05 TW TW092124641A patent/TW200418392A/zh unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04311357A (ja) * | 1991-04-05 | 1992-11-04 | Api Kk | ローヤルゼリーエキスの製造法 |
US5543513A (en) * | 1992-12-02 | 1996-08-06 | Kabushiki Kaisha Hayashibara | Trehalose desiccant product and dehydration therewith |
JPH11146759A (ja) * | 1997-11-18 | 1999-06-02 | Kirin Beverage Corp | 10−ヒドロキシ−2−デセン酸配合コーヒー含有飲料 |
JP2000060455A (ja) * | 1998-08-26 | 2000-02-29 | Api Co Ltd | ローヤルゼリーエキス及びローヤルゼリーエキス含有製品の製造方法 |
JP2001061418A (ja) * | 1999-08-30 | 2001-03-13 | Pola Chem Ind Inc | ローヤルゼリー中の有効成分の精製法 |
JP2002112715A (ja) * | 2000-10-03 | 2002-04-16 | Api Co Ltd | 低アレルゲン化ローヤルゼリー及びその製造方法 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1547472A4 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034938A1 (ja) * | 2003-10-07 | 2005-04-21 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | コラーゲン産生増強剤とその製造方法並びに用途 |
JP2006016387A (ja) * | 2004-06-04 | 2006-01-19 | Jrj Pharmaceutical Co Ltd | 新規なローヤルゼリー配合物 |
JP2009508477A (ja) * | 2005-09-19 | 2009-03-05 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 茶製造のための改良された方法 |
JP2008067632A (ja) * | 2006-09-13 | 2008-03-27 | Japan Royal Jelly Co Ltd | 動物用サプリメントおよびペット用サプリメント |
WO2008149838A1 (ja) * | 2007-06-04 | 2008-12-11 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 新規ローヤルゼリー分画物とその製造方法並びに用途 |
JP5479891B2 (ja) * | 2007-06-04 | 2014-04-23 | 株式会社林原 | 新規ローヤルゼリー分画物とその製造方法並びに用途 |
JP2010090112A (ja) * | 2008-09-11 | 2010-04-22 | Queen Bee Garden:Kk | 遺伝子発現抑制剤および遺伝子発現促進剤並びにそれらの検出方法 |
JP2012080828A (ja) * | 2010-10-12 | 2012-04-26 | Kato Bihoen Honpo:Kk | ローヤルゼリー |
US10004711B2 (en) | 2014-05-08 | 2018-06-26 | Dsm Ip Assets B.V. | Methods and compositions comprising 10-hydroxy-2-decenoic acid |
KR20150136857A (ko) | 2014-05-28 | 2015-12-08 | 대한민국(농촌진흥청장) | 알레르기성이 감소된 수용성 로열젤리를 포함하는 피부 미백 및 노화방지용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
US20060159834A1 (en) | 2006-07-20 |
BR0306294A (pt) | 2004-09-28 |
JP4384981B2 (ja) | 2009-12-16 |
JPWO2004021803A1 (ja) | 2005-12-22 |
CN1688209A (zh) | 2005-10-26 |
EP1547472A1 (en) | 2005-06-29 |
EP1547472A4 (en) | 2006-04-26 |
TW200418392A (en) | 2004-10-01 |
KR20050057127A (ko) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004021803A1 (ja) | 精製ローヤルゼリー | |
JP5050350B2 (ja) | コラーゲン産生増強剤とその製造方法並びに用途 | |
AU2004224492B2 (en) | Method of powdering nonsugar component and powdering base | |
CN102858356A (zh) | 以海带提取物为有效成分的抗菌辅助剂、抗菌组合物、以及饮食品 | |
JP2003135028A (ja) | 健康機能食品 | |
JP2008056572A (ja) | ジンゲロール含有水溶性組成物、該ジンゲロール含有水溶性組成物の製造方法、及び該ジンゲロール含有水溶性組成物を含有する飲食品、化粧品、医薬品 | |
JP2007176919A (ja) | カルコン類化合物含有組成物 | |
JP4502549B2 (ja) | 水分散性又は水溶解性のイチョウ葉抽出物組成物 | |
WO2018180727A1 (ja) | フコース含有組成物の製造方法、そのフコース含有組成物を含有する飲食品、化粧品、トイレタリー用品、医薬部外品、及び医薬品の製造方法 | |
JPWO2004112817A1 (ja) | セリ科植物由来抽出物およびその製造方法 | |
JP2009062336A (ja) | 心不全予後改善剤 | |
WO2007007994A1 (en) | Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract | |
KR20030005187A (ko) | 세포 부활제 | |
KR102461788B1 (ko) | 누에동충하초(눈꽃동충하초) 물 추출물을 포함하는 면역 증진용 조성물 | |
JP6534275B2 (ja) | 骨砕補エキス組成物 | |
JP6753917B2 (ja) | 渋味抑制剤及びその製造方法 | |
JP2017043610A (ja) | 二日酔いの予防又は改善剤、肝機能改善剤 | |
KR101848580B1 (ko) | 갈변 현상이 방지된 떫은감 추출물을 유효성분으로 함유하는 식품 조성물 | |
JP2007045750A (ja) | 抗疲労剤 | |
CN1275083A (zh) | α-葡萄糖苷酶抑制剂 | |
WO2023195538A1 (ja) | サツマイモ由来のイモ蜜、その上清、又はこれら双方の粉末又は顆粒からなるイモ蜜粉 | |
JP2011051901A (ja) | α−グルコシダーゼ阻害剤 | |
WO2004019962A1 (ja) | 経口用育毛剤 | |
KR102672925B1 (ko) | 녹용 추출물을 포함하는 키 성장 촉진용 조성물 | |
JP6812032B2 (ja) | 羅漢果抽出物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CN JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004534159 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003794234 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057003666 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: 2006159834 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10525157 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038237652 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057003666 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2003794234 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10525157 Country of ref document: US |